Mobile-Thrive - A Family Self-Management Approach to Failure to Thrive

Status Terminated

Clinical Trial Summary

Failure to Thrive negatively affects growth, cognition, behavior, and quality of life (QoL), which can be devastating and enduring. These outcomes are high-cost and lead to increased family stress and negatively affect the caregiver-child relationship. Therefore, families need increased access to materials that will help them understand their child's health and help them use new feeding behaviors to improve the child's nutrition and growth. Standard care with the addition of Mobile Thrive (M-Thrive), our innovative smart phone-based mobile app, is intended to demonstrate the clinical advantages of using mobile health technology (mHealth) in comparison to standard care alone.

Clinical Trial Description

Families will be randomly assigned to either the Standard Care plus access to the Mobile-Thrive (M-Thrive) application or Standard Care alone. All families will complete a 24-hour dietary recall, Feeding Strategies Questionnaire (FSQ), PedsQL Family Impact Module (PedsQL FIM), and Pediatric Inventory for Parents (PIP) at pre/post treatment. It will take about 45 minutes to complete these measures. Anthropometric measurements will be collected at pretreatment, 6 weeks, and 3 months. Families receiving standard care alone will have regularly scheduled visits in the Nutritional Care Program and will have access to standard care resources, including phone contacts and electronic access through the CHW hospital portal. Specifically, standard care treatment provides dietary and behavioral instructions on appropriate beverage intake, appropriate feeding regimen, advice on limiting low-calorie foods, and multivitamin supplementation, if appropriate. Families in the standard care plus the M-Thrive application will receive the standard care treatment that is described above, as well as on-demand resources, daily educational text messages, and family self-management push notifications through the M-Thrive application. The research team will train families on the use of the M-Thrive application and families in the standard care plus M-Thrive application can contact their provider through the application with questions and/or concerns. At the conclusion of the intervention, qualitative data regarding the participants' experience will be collected. Specifically, 90-minute focus group sessions will occur within 2 weeks of concluding the 3 month active phase of treatment. Families will be asked to discuss factors that affected their ability to sustain condition management recommendations, their efforts to access health care resources, factors that affect family quality of life and caregiver stress, and family impressions of what else would help to build support for families managing FTT. All sessions will be transcribed and coded for content analysis. ;

Study Design

Related Conditions & MeSH terms

Failure to Thrive

Clinical Trial Details

NCT number	NCT02589132
Study type	Interventional
Source	Medical College of Wisconsin
Contact
Status	Terminated
Phase	N/A
Start date	August 2015
Completion date	December 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05289674` - The Effect of Lactoferrin in High Calorie Formula on IL-6 and IL10 in Children With Failure to Thrive and Infection	N/A
Completed	`NCT05333133` - High Calorie Formula Intervention on Weight, Length Increment, Total Lymphocyte Counts, TNF-alpha and IGF-1 in Failure to Thrive Children	N/A
Completed	`NCT03202576` - Nasogastric Tube Securement Comparison Study	N/A
Completed	`NCT01338363` - Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists	N/A
Completed	`NCT02879357` - Palliative Care Population Management Project for Integrated Care Management Program for High-Risk Patients	N/A
Completed	`NCT04393909` - Improving Safety of Diagnosis and Therapy in the Inpatient Setting	N/A
Not yet recruiting	`NCT01772927` - Clinical Tolerance of Numeta 13%	N/A
Completed	`NCT02128984` - Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children	N/A
Completed	`NCT01070173` - Ghrelin Levels in Children With Poor Growth	N/A
Completed	`NCT00483691` - Trial of Home Visitation Among Infants With Failure To Thrive	N/A
Completed	`NCT00190658` - Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome	Phase 3
Completed	`NCT02647580` - Appetite Regulation in Children With Failure to Thrive	N/A
Recruiting	`NCT01314989` - Cyproheptadine as an Appetite Stimulant	Phase 4
Completed	`NCT00001639` - Evaluation of Patients With Unresolved Chromosome Abnormalities	N/A
Completed	`NCT04985227` - Impact of Home Weight Tele-monitoring on the Number of Office Visits in the First Six Weeks of Life in Infants.	N/A
Terminated	`NCT02710383` - Biomarker for Cystic Fibrosis
Completed	`NCT00325611` - Multidisciplinary Inpatient Palliative Care Intervention	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.